A number of studies have established that tumors can actively induce tumor-associated lymphangiogenesis by secreting appropriate growth factors such as vascular endothelial growth factor- (VEGF-) C, VEGF-D, or VEGF-A and EGF [41, 42]. The gene discussed is EGF; the disease is neoplasm.